fda warning letter bpc-157 dietary supplement issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA panel narrowly backs unapproved

doi: 10.1016/j.phrs.2021.105465 61 ChuLValenciaIJGarvertDWMontoyaJG

The NCAA drug testing handbook says D-I and D-II athletic departments are, under most circumstances, notified at least two days in advance of a visit from testers

On July 23 and 24, 2026, the US Food and Drug Administration's Pharmacy Compounding Advisory Committee reviewed BPC-157, KPV, TB-500, MOTS-c and other peptides for possible inclusion on the section 503A bulk drug substances list, which governs what US compounding pharmacies may prepare

While injections often may support recovery goals for muscle and joint injuries, oral capsules are a convenient option for gut-focused support